Vona Oncology was recently featured in Colorado's 5280 Magazine highlighting advancement in cancer care and research and innovation to improve the lives of patients diagnosed with cancer!
Member Success: Congratulations to the teams at Vona Oncology, Foresight Diagnostics Inc., Biodesix, Inc. and aiGENE, on being featured in 5280 Magazine for your trailblazing innovations in cancer care. CBSA proudly champions life sciences in Colorado. We were thrilled to work with the 5280 editorial team to highlight member companies developing leading-edge innovations that are advancing cancer diagnostics and treatments. The new 5280 Magazine article shines a light on how Colorado oncologists are “saving more lives than ever before, while researchers continue to search for ways to save everyone.” - Based at Fitzsimons Innovation Community, Vona Oncology’s wonder drug is aimed at treating triple-negative breast cancer and Foresight Diagnostics’ blood tests are sensitive enough to detect cancers below one part per million DNA fragment - aiGENE, also based at Fitzsimons Innovation Community, charts changes in DNA, an innovation promising enough to warrant grants from the Office of Economic Development and International Trade's Advanced Industries Accelerator Program - Boulder's Biodesix manufactures two blood exams already being widely used Learn more: https://lnkd.in/gqg5jtDV #CoBioScience #StrongerTogether #InnovationForward #BuildingMomentum